ArticleDiabetes care2019

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults.

Tiansheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.